Black Rock Inc. Iovance Biotherapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 21,225,119 shares of IOVA stock, worth $47.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

21,225,119

Previous 19,929,702 6.5%

Holding current value

$47.3 Million

Previous $295 Million 42.37%

% of portfolio

0.0%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$7.78 - $14.19 $10.1 Million - $18.4 Million	1,295,417 Added 6.5%	21,225,119 $170 Million
Q1 2024 May 10, 2024	BUY	$7.59 - $17.47 $6.51 Million - $15 Million	857,946 Added 4.5%	19,929,702 $295 Million
Q4 2023 Feb 13, 2024	BUY	$3.3 - $8.89 $2.29 Million - $6.18 Million	695,327 Added 3.78%	19,071,756 $155 Million
Q3 2023 Nov 13, 2023	BUY	$4.44 - $8.79 $6.1 Million - $12.1 Million	1,374,638 Added 8.09%	18,376,429 $83.6 Million
Q2 2023 Aug 11, 2023	BUY	$5.36 - $9.06 $24.4 Million - $41.2 Million	4,545,129 Added 36.49%	17,001,791 $120 Million
Q1 2023 May 12, 2023	BUY	$5.53 - $8.22 $2.1 Million - $3.12 Million	379,560 Added 3.14%	12,456,662 $76.1 Million
Q4 2022 Feb 13, 2023	BUY	$5.62 - $10.0 $3.43 Million - $6.11 Million	610,610 Added 5.33%	12,077,102 $77.2 Million
Q3 2022 Nov 14, 2022	SELL	$9.53 - $13.11 $996,590 - $1.37 Million	-104,574 Reduced 0.9%	11,466,492 $110 Million
Q2 2022 Aug 12, 2022	BUY	$6.38 - $18.33 $26.4 Million - $75.9 Million	4,142,074 Added 55.76%	11,571,066 $128 Million
Q1 2022 May 12, 2022	BUY	$12.38 - $19.1 $253,629 - $391,301	20,487 Added 0.28%	7,428,992 $124 Million
Q4 2021 Feb 10, 2022	BUY	$16.55 - $27.63 $7.62 Million - $12.7 Million	460,699 Added 6.63%	7,408,505 $141 Million
Q3 2021 Nov 09, 2021	BUY	$20.35 - $26.63 $3.66 Million - $4.78 Million	179,637 Added 2.65%	6,947,806 $171 Million
Q2 2021 Aug 11, 2021	BUY	$16.33 - $33.07 $111 Million - $224 Million	6,768,169 New	6,768,169 $176 Million

Others Institutions Holding IOVA

# of Institutions

287

Shares Held

233M

Call Options Held

1.12M

Put Options Held

1.15M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $352M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account